Singapore markets open in 7 hours 46 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,049.67 +31.28 (+0.62%) Dow
38,137.97 +234.68 (+0.62%) Nasdaq
15,774.34 +168.85 (+1.08%) Bitcoin USD
59,000.14 +2,207.52 (+3.89%) CMC Crypto 200
1,272.53 +1.78 (+0.14%)
ABT Jun 2024 60.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:22AM EDT. Market open.
| Previous close | 50.35 |
| Open | 50.35 |
| Bid | 43.75 |
| Ask | 44.65 |
| Strike | 60.00 |
| Expiry date | 2024-06-21 |
| Day's range | 50.35 - 50.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.